Compare · APDN vs HRB
APDN vs HRB
Side-by-side comparison of Applied DNA Sciences Inc. (APDN) and H&R Block Inc. (HRB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APDN and HRB operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- HRB is the larger of the two at $6.56B, about 273.7x APDN ($24.0M).
- Over the past year, APDN is up 69.8% and HRB is up 5.7% - APDN leads by 64.1 points.
- HRB has hit the wire 4 times in the past 4 weeks while APDN has been quiet.
- HRB has more recent analyst coverage (4 ratings vs 2 for APDN).
- Company
- Applied DNA Sciences Inc.
- H&R Block Inc.
- Price
- -
- -
- Market cap
- $24.0M
- $6.56B
- 1M return
- +142.31%
- +25.62%
- 1Y return
- +69.76%
- +5.67%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 4
- Recent ratings
- 2
- 4
Applied DNA Sciences Inc.
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
H&R Block Inc.
H&R Block, Inc., through its subsidiaries, provides assisted income tax return preparation and do-it-yourself (DIY) tax return preparation services and products to the general public primarily in the United States, Canada, and Australia. The company offers assisted income tax return preparation and related services through a system of retail offices operated directly by the company or its franchisees. It also provides DIY tax services and products, including federal and state income tax returns, access to tax tips, advice and tax-related news, use of calculators for tax planning, and error checking and electronic filing; and software online, as well as through third-party retail stores. In addition, the company offers Refund Transfers and H&R Block Emerald Prepaid Mastercard, which enables clients to receive their tax refunds; Peace of Mind extended service plans; H&R Block Emerald Advance lines of credit; Tax Identity Shield that provides clients assistance in helping protect their tax identity and access to services to help restore their tax identity; refund advance loans; H&R Block Instant Refund; and H&R Block Pay With Refund services. Further, it provides small business financial solutions through its company-owned or franchise offices, and online. H&R Block, Inc. was founded in 1955 and is headquartered in Kansas City, Missouri.
Latest APDN
- SEC Form DEFA14A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Leadership Update
- SEC Form DEF 14A filed by Applied DNA Sciences Inc.
- SEC Form 424B5 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Applied DNA Sciences Inc.
- SEC Form S-1 filed by Applied DNA Sciences Inc.
- Applied DNA Sciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest HRB
- Chief Legal & Admin. Officer Redler Dara S was granted 17,271 shares, increasing direct ownership by 40% to 60,629 units (SEC Form 4)
- SEC Form 10-K filed by H&R Block Inc.
- H&R Block Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- H&R Block Reports Fiscal 2026 Results and Enters Fiscal 2027 with Confidence
- H&R Block to Release Fiscal 2026 Results on August 11, 2026
- Stephens initiated coverage on H & R Block with a new price target
- President & CEO Campbell Curtis A covered exercise/tax liability with 11 shares, decreasing direct ownership by 0.03% to 42,987 units (SEC Form 4)
- President & CEO Campbell Curtis A covered exercise/tax liability with 1,016 shares, decreasing direct ownership by 2% to 42,558 units (SEC Form 4)
- SEC Form 10-Q filed by H&R Block Inc.
- H&R Block Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits